DarioHealth ( DRIO ) shares surged in pre-market trading Monday after the digital health company said the US Food and Drug Administration (FDA) has granted pre-market notification (510(k)) clearance for the company’s lightning-enabled version of the acclaimed Dario Blood Glucose Monitoring System which enables the use of the Dario app on iPhone 7, 8 and X smart mobile devices.

Read more on Nasdaq here.